Equity Overview
Price & Market Data
Price: $9.09
Daily Change: +$0.27 / 2.97%
Daily Range: $9.00 - $9.09
Market Cap: $779,068,480
Daily Volume: 1,378
Performance Metrics
1 Week: 14.10%
1 Month: -1.56%
3 Months: -7.55%
6 Months: -7.84%
1 Year: 53.12%
YTD: -15.11%
Company Details
Employees: 260
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.